Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

News provided by

Jun 15, 2014, 08:00 ET

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/treatments/hormone_sensitive_prostate_cancer_global_clinical_trials_review_h1_2014.html

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014" provides data on the Hormone-Sensitive Prostate Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hormone-Sensitive Prostate Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hormone-Sensitive Prostate Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction 5
Hormone-Sensitive Prostate Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Hormone-Sensitive Prostate Cancer to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Hormone-Sensitive Prostate Cancer 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Novartis AG 26
Clinical Trial Overview of Novartis AG 26
Ferring International Center S.A. 27
Clinical Trial Overview of Ferring International Center S.A. 27
Johnson & Johnson 28
Clinical Trial Overview of Johnson & Johnson 28
GlaxoSmithKline plc 29
Clinical Trial Overview of GlaxoSmithKline plc 29
Dendreon Corporation 30
Clinical Trial Overview of Dendreon Corporation 30
CMX Research Inc. 31
Clinical Trial Overview of CMX Research Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
National Cancer Institute 32
Clinical Trial Overview of National Cancer Institute 32
Massachusetts General Hospital 33
Clinical Trial Overview of Massachusetts General Hospital 33
University of California, San Francisco 34
Clinical Trial Overview of University of California, San Francisco 34
Azienda Provinciale per i Servizi Sanitari 35
Clinical Trial Overview of Azienda Provinciale per i Servizi Sanitari 35
Comprehensive Cancer Centers of Nevada 36
Clinical Trial Overview of Comprehensive Cancer Centers of Nevada 36
City of Hope National Medical Center 37
Clinical Trial Overview of City of Hope National Medical Center 37
Oslo University Hospital 38
Clinical Trial Overview of Oslo University Hospital 38
Keio University 39
Clinical Trial Overview of Keio University 39
Barbara Ann Karmanos Cancer Institute 40
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 40
University of Pennsylvania 41
Clinical Trial Overview of University of Pennsylvania 41
Five Key Clinical Profiles 42
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 83
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84

List of Tables

Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Hormone-Sensitive Prostate Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Hormone-Sensitive Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hormone-Sensitive Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 20
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Hormone-Sensitive Prostate Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 26
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2014* 27
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 28
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 29
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dendreon Corporation, 2014* 30
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by CMX Research Inc., 2014* 31
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 32
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 33
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 34
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Provinciale per i Servizi Sanitari, 2014* 35
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Comprehensive Cancer Centers of Nevada, 2014* 36
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 37
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2014* 38
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2014* 39
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014* 40
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 41

Li

st of Figures

Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Hormone-Sensitive Prostate Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Hormone-Sensitive Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hormone-Sensitive Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Hormone-Sensitive Prostate Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Hormone-Sensitive Prostate Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 82